What we found on the web about Janumet
Janumet (sitagliptin / metformin) - an oral anti-diabetic drug for the treatment of type 2 diabetes. Januvia (sitagliptin) - a dipeptidyl peptidase-4 inhibitor for the treatment of ...
... trade name Metaglip) and glibenclamide (known as glyburide in the United States, trade name Glucovance), the dipeptidyl peptidase-4 inhibitor sitagliptin (trade name Janumet), and the ...
Enrollment. CRIXIVAN ® (indinavir sulfate) ISENTRESS ® (raltegravir) GARDASIL ® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]
Some of the most commonly reported Janumet side effects include diarrhea, abdominal pain, and nausea. This eMedTV segment also lists serious side effects of the drug that may ...
The Janumet dosage that your doctor prescribes will depend on your existing metformin or sitagliptin dosage. This eMedTV article explains in more detail how Janumet dosing works ...
Januvia (sitagliptin) is a type 2 diabetes drug that was approved in 2006. It is also available in a combination pill (known as Janumet) that contains the drug metformin. They are ...
Should Janumet be approved on time, it's likely these new sales estimates will become a reality. It is widely known that used in combination, Januvia and metformin have produced ...
Janumet WisdomCard ™ Our Guides and Physician Review team have organized the Top 10 Health Resources on Janumet and compiled helpful research notes below.
Comprehensive pharmaceutical information from Merckproductservices.com including product samples, prescribing information, physician webcasts and educational resources.
Find patient medical information for Janumet Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
Here is what users have to say about Janumet

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only second generation DPP-4 inhibitor currently available in the USA. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) also works by its effect on the incretin system.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!